search
Back to results

Do AxoGuard Implants Decrease Shoulder Disability After Neck Dissections

Primary Purpose

Spinal Accessory Nerve Injury, Cervical Lymphadenopathy

Status
Unknown status
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
AxoGuard Nerve Cuff
Sponsored by
University of Mississippi Medical Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Spinal Accessory Nerve Injury

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

-Any neck dissection (cervical lymphadenectomy) that involves resection of level 2 cervical lymph nodes for malignancy and does not fall into the categories listed under the exclusion criteria.

Exclusion Criteria:

  1. History of modified radical neck dissection involving removal of spinal accessory nerve or sternocleidomastoid muscle
  2. History of radical neck dissection
  3. History of pre- existing disabling shoulder complaints
  4. <18 years of age
  5. Any individual unable to provide consent for his/her self.
  6. Any individual with allergy, sensitivity, or aversion to porcine material.

Sites / Locations

  • University of Mississippi Medical CenterRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Placebo Comparator

Experimental

Arm Label

Control

Interventional

Arm Description

Patients who provide consent for implant placement but do not receive the implant.

Patients who provide consent for implant placement and do receive the implant.

Outcomes

Primary Outcome Measures

Shoulder function
Shoulder function will be assessed by Constant-Murley shoulder scale. The Constant-Murley shoulder scale is a validated subjective and objective survey of overall shoulder function. The scale ranges from 0 (no shoulder function) to 100 (perfect shoulder function). It consists of several questions about pain and disability as well as actual shoulder testing that will be performed by the consenting physician during the participant's clinic appointment.

Secondary Outcome Measures

Postoperative pain following neck dissection: rate shoulder pain from 1-10
The comparison of the improvement or change in pain scores over 6 months between the control group and intervention group will be assessed at each clinical visit over the course of 6 months.

Full Information

First Posted
May 1, 2019
Last Updated
May 6, 2019
Sponsor
University of Mississippi Medical Center
search

1. Study Identification

Unique Protocol Identification Number
NCT03941327
Brief Title
Do AxoGuard Implants Decrease Shoulder Disability After Neck Dissections
Official Title
Do AxoGuard Implants Decrease Shoulder Disability After Neck Dissections
Study Type
Interventional

2. Study Status

Record Verification Date
May 2019
Overall Recruitment Status
Unknown status
Study Start Date
May 1, 2019 (Actual)
Primary Completion Date
May 1, 2020 (Anticipated)
Study Completion Date
May 1, 2020 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Mississippi Medical Center

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of this study is to determine whether Axoguard nerve protectors have a role in preventing shoulder disability and pain following spinal accessory nerve sparing neck dissections.
Detailed Description
The spinal accessory nerve is often manipulated during selective neck dissections in order to remove the fibrofatty tissues containing lymph nodes surrounding the nerve. Afterwards the nerve is left exposed without it's normal support making it vulnerable to adhesions, compression, and stretch injury. Axoguard nerve wraps have shown significant promise in preventing the recurrence of carpal tunnel following forearm surgery, and preventing impotence and incontinence following nerve sparing robotic radical prostatectomy. The investigators hypothesize that the same technology may aid in reducing shoulder disability and pain if used in spinal accessory nerve sparing neck dissections. In this prospective single blinded randomized controlled study the investigators will randomly assign patients to a control group that will not receive the AxoGuard nerve wrap, and a study group that will receive the AxoGuard nerve wrap around their exposed spinal accessory nerve(s) using a research randomization tool. The results will be stratified into groups including preoperative and postoperative stage of disease, preoperative and postoperative nodal (neck) stage, history of radiation, and whether or not level 2B was dissected. Individuals with a history of pre-existing disabling shoulder complaints, individuals under the age of 18, individuals who cannot provide their own informed consent, and individuals undergoing a neck dissection that will remove the sternocleidomastoid muscle or spinal accessory nerve will be excluded from the study. Patients will undergo preoperative shoulder assessment using the Constant-Murley shoulder outcome score at their initial clinical visit. Postoperative outcomes will be recorded at 2 weeks, 2 months, 4 months, and 6 months and measured by the Shoulder Disability Questionnaire, Rand-36 quality of life survey, pain scale, and Constant-Murley shoulder outcome score. With this study the investigators aim to show a clinically significant improvement in shoulder function following spinal accessory nerve sparing neck dissections when AxoGuard nerve wraps are used to protect the nerve. Additionally, the investigators aim to improve patient satisfaction, decrease post-op pain, and improve quality of life.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Spinal Accessory Nerve Injury, Cervical Lymphadenopathy

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Masking Description
Patients will be randomly assigned to a control group or intervention group using a computer based randomization tool. Patient's undergoing bilateral neck dissection will receive an implant on one side and act as self control.
Allocation
Randomized
Enrollment
100 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Control
Arm Type
Placebo Comparator
Arm Description
Patients who provide consent for implant placement but do not receive the implant.
Arm Title
Interventional
Arm Type
Experimental
Arm Description
Patients who provide consent for implant placement and do receive the implant.
Intervention Type
Device
Intervention Name(s)
AxoGuard Nerve Cuff
Intervention Description
A porcine collagen implant will be used to make a protective sheath around the participant's exposed spinal accessory nerve during surgery. This will be performed by physically wrapping the exposed nerve with the implant and suturing the ends together. The goal is to protect nerve from adhesions and compression in the absence of normal protective lymphatic soft tissue.
Primary Outcome Measure Information:
Title
Shoulder function
Description
Shoulder function will be assessed by Constant-Murley shoulder scale. The Constant-Murley shoulder scale is a validated subjective and objective survey of overall shoulder function. The scale ranges from 0 (no shoulder function) to 100 (perfect shoulder function). It consists of several questions about pain and disability as well as actual shoulder testing that will be performed by the consenting physician during the participant's clinic appointment.
Time Frame
The comparison of improvement or change in shoulder function over 6 months between the control and intervention groups will be the primary outcome measure.
Secondary Outcome Measure Information:
Title
Postoperative pain following neck dissection: rate shoulder pain from 1-10
Description
The comparison of the improvement or change in pain scores over 6 months between the control group and intervention group will be assessed at each clinical visit over the course of 6 months.
Time Frame
Patients will be asked to rate shoulder pain from 1-10 at each postoperative visit over the course of 6 months.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: -Any neck dissection (cervical lymphadenectomy) that involves resection of level 2 cervical lymph nodes for malignancy and does not fall into the categories listed under the exclusion criteria. Exclusion Criteria: History of modified radical neck dissection involving removal of spinal accessory nerve or sternocleidomastoid muscle History of radical neck dissection History of pre- existing disabling shoulder complaints <18 years of age Any individual unable to provide consent for his/her self. Any individual with allergy, sensitivity, or aversion to porcine material.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Jaxon W Jordan, M.D.
Phone
325-370-2063
Email
jwjordan@umc.edu
First Name & Middle Initial & Last Name or Official Title & Degree
Gina Jefferson, M.D.
Phone
3124339898
Email
gjefferson@umc.edu
Facility Information:
Facility Name
University of Mississippi Medical Center
City
Jackson
State/Province
Mississippi
ZIP/Postal Code
39216
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Gina Jefferson
Phone
312-433-9898
Email
gjefferson@umc.edu

12. IPD Sharing Statement

Plan to Share IPD
Undecided

Learn more about this trial

Do AxoGuard Implants Decrease Shoulder Disability After Neck Dissections

We'll reach out to this number within 24 hrs